CD4 and cancer: The favorable impact of high CD19+ B cells, CD4+ T cells (8, 9, 19), and the CD4+/CD8+ ratio, along with the adverse association of elevated CD8+ T cells (10) with outcome, aligns with findings in other cancers where such an immune profile indicates tumor-induced immunosuppression (20).